首页> 外文会议>International Congress on Coronary Artery Disease >Circulating Pro-inflammatory and Anti-inflammatory Cytokines in Patients with Unstable Angina Pectoris
【24h】

Circulating Pro-inflammatory and Anti-inflammatory Cytokines in Patients with Unstable Angina Pectoris

机译:在不稳定的心绞痛患者中循环促炎和抗炎细胞因子

获取原文

摘要

Recent data indicate that CAD patients differ in their susceptibility to inflammatory status on the basis of their cytokine profiles. We investigated whether interleukin-1beta (IL-1P), IL-8 and IL-4 are indicative of unstable angina and whether they are influenced with atorvastatin. Patients were divided into group 1( 22 patients with unstable angina) and group 2 (23 patients with stable angina). Mean serum concentrations of IL-1beta, IL-8 were increased in group 1 (4,0+-0,72; 11,4 +-3,5pg/mL) vs group 2(l,5+-0,32; 2,1+-1,1 pg/mL). On the contrary, IL-4 level was lower in group 1. Atorvastatin treatment 10 mg daily reduced IL-8 serum concentration in patients with unstable angina, but had no effect in group 2. Our data confirm the role of cytokine disbalance in pathogenesis of unstable angina and nonlipid effect of atorvastatin.
机译:最近的数据表明,CAD患者在其细胞因子谱的基础上对炎症状态的敏感性不同。我们研究了白细胞介素-1beta(IL-1p),IL-8和IL-4是否指示不稳定的心绞痛,以及它们是否受到阿托伐他汀的影响。患者分为第1组(22例不稳定的心绞痛患者)和第2组(23例稳定心绞痛患者)。 IL-1Beta的平均血清浓度在1(4,0±0,72; 11,4 + -3,5pg / ml)中增加IL-1,IL-8增加(L,5 + -0,32; 2,1 + -1,1 pg / ml)。相反,IL-4级别较低,群体1.阿托伐他汀治疗10毫克每日降低IL-8血清血清浓度,患者在不稳定的心绞痛中,但在第2组中没有任何影响。我们的数据确认了细胞因子患者在发病机制中的作用。阿托伐他汀的不稳定心绞痛和非脂质作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号